HIV testing rates and outcomes in a south african community, 2001-2006: Implications for expanded screening policies

Journal of Acquired Immune Deficiency Syndromes

Volumn 51, Issue 3, 2009, Pages 310-316

  April, Michael D ^a,b,c   Walensky, Rochelle P ^a,c,d   Chang, Yuchiao ^c   Pitt, Jennifer ^e   Freedberg, Kenneth A ^a,c,f,g   Losina, Elena ^a,c,d,f   Paltiel, A David ^h   Wood, Robin ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEALTH CARE FACILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL RECORD; PATIENT CARE; PRIORITY JOURNAL; SCREENING TEST; SEROCONVERSION; SERODIAGNOSIS; SOUTH AFRICA; WORLD HEALTH ORGANIZATION; HEALTH CARE POLICY; MIDDLE AGED; STATISTICS;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH POLICY; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; SOUTH AFRICA; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 67651028095     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181a248e6     Document Type: Article

References (29)

1. WHO/UNAIDS. Guidance on Provider-Initiated HIV Testing and Counselling in Health Facilities. Geneva, Switzerland: World Health Organization, Joint United Nations Programme on HIV/AIDS; 2007. Available at: http://www.who.int/ hiv/pub/guidelines/9789241595568-en.pdf. Accessed September 10, 2008.
2. De Cock K, Bunnell R, Mermin J. Unfinished business - expanding HIV testing in developing countries. N Engl J Med. 2006;354:440-442.
3. De Cock K, Marum E, Mbori-Ngacha D. A serostatus-based approach to HIV/AIDS prevention and care in Africa. Lancet. 2003;362:1847-1849.
4. UNAIDS. AIDS Epidemic Update. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2007. Available at: http://data.unaids.org/pub/ EPISlides/2007/2007-epiupdate-en.pdf. Accessed September 10, 2008.
5. Shisana O, Rehle T, Simbayi L, et al. South African National HIV Prevalence, HIV Incidence, Behaviour and Communication Survey, 2005. Cape Town, South Africa: Human Sciences Research Council; 2005. Available at: http://www.hsrcpress.ac.za/product.php?productid=2134. Accessed September 10, 2008.
6. Homsy J, Kalamya JN, Obonyo J, et al. Routine intrapartum HIV counseling and testing for prevention of mother-to-child transmission of HIV in a rural Ugandan hospital. J Acquir Immune Defic Syndr. 2006;42: 149-154.
7. Zachariah R, Spielmann MP, Harries AD, et al. Voluntary counselling, HIV testing and sexual behaviour among patients with tuberculosis in a rural district of Malawi. Int J Tuberc Lung Dis. 2003;7:65-71.
8. Arthur GR, Ngatia G, Rachier C, et al. The role for government health centers in provision of same-day voluntary HIV counseling and testing in Kenya. J Acquir Immune Defic Syndr. 2005;40:329-335.
9. Bassett IV, Giddy J, Nkera J, et al. Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department. J Acquir Immune Defic Syndr. 2007;46:181-186.
10. Lawn SD, Bekker LG, Middelkoop K, et al. Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin Infect Dis. 2006;42: 1040-1047.
11. Wood R, Middelkoop K, Myer L, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med. 2007;175:87-93.
12. Bharat S, Mahendra VS, Meeting the sexual and reproductive health needs of people living with HIV: challenges for health care providers. Reprod Health Matters. 2007;15:93-112.
13. WHO. Guidelines on Cotrimoxazole Prophylaxis for HIV-Related Infections Among Children, Adolescents and Adults. Geneva, Switzerland: World Health Organization; 2006. Available at: http://www.who.int/hiv/pub/ guidelines/ctxguidelines.pdf. Accessed September 10, 2008.
14. WHO. Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Geneva, Switzerland: World Health Organization; 2006. Available at: http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf. Accessed September 10, 2008.
15. DTHF. The Desmond Tutu HIV Foundation. Cape Town, South Africa: Desmond Tutu HIV Foundation; 2007. Available at: www. desmondtutuhivcentre.org. za. Accessed March 9, 2008.
16. Dorrington RE, Bradshaw D, Johnson L, et al. The Demographic Impact of HIV/AIDS in South Africa: National and Provincial Indicators for 2006. Cape Town, South Africa: Centre for Actuarial Research, the Burden of Disease Research Unit (Medical Research Council), and the Actuarial Society of South Africa; 2006. Available at: http://www.mrc.ac.za/bod/ DemographicImpactHIVIndicators.pdf. Accessed September 10, 2008.
17. WHO. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: World Health Organization; 2006. Available at: http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf.
18. Heitjan DF, Basu A. Distinguishing 'missing at random' and 'missing completely at random'. J Am Stat Assoc. 1996;50:207-213.
19. WHO/UNAIDS/UNICEF. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Geneva, Switzerland: World Health Organization, Joint United Nations Programme on HIV/AIDS, United Nations Children's Fund; 2007. Available at: http://www.who.int/hiv/mediacentre/ univeral-access-progress-report-en.pdf. Accessed September 10, 2008.
20. Warwick Z. The influence of antiretroviral therapy on the uptake of HIV testing in Tutume, Botswana. Int J STD AIDS. 2006; 17:479-481.
21. Creek TL, Ntumy R, Seipone K, et al. Successful introduction of routine opt-out HIV testing in antenatal care in Botswana. J Acquir Immune Defic Syndr. 2007;45:102-107.
22. Urban M, Chersich M. Acceptability and utilisation of voluntary HIV testing and nevirapine to reduce mother-to-child transmission of HIV-1 integrated into routine clinical care. S Afr Med J. 2004;94:362-366.
23. Stringer EM, Sinkala M, Stringer JS, et al. Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS. 2003;17: 1377-1382.
24. de Paoli MM, Manongi R, Klepp KI. Factors influencing acceptability of voluntary counselling and HIV-testing among pregnant women in Northern Tanzania. AIDS Care. 2004;16:411-425.
25. Menzies N, Abang B, Wanyenze R, et al. The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS. 2008;23: 395-401.
26. Badri M, Cleary S, Maartens G, et al. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antivir Ther. 2006; 11:63-72.
27. Ojikutu B, Jack C, Ramjee G. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles. J Infect Dis. 2007; 196(Suppl 3):S523-S527.
28. Kalichman SC, Simbayi LC. HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa. Sex Transm Infect. 2003;79:442-447.
29. Steen TW, Seipone K, Gomez Fde L, et al. Two and a half years of routine HIV testing in Botswana. J Acquir Immune Defic Syndr. 2007;44:484-488.